Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/ex-theseus-execs-extend-gist-mission-by-taking-helm-of-idrx/
https://www.prnewswire.com/news-releases/theseus-pharmaceuticals-announces-closing-of-tender-offer-302061474.html
https://www.fiercebiotech.com/biotech/concentra-scores-another-win-theseus-agrees-buyout-offer
https://www.prnewswire.com/news-releases/theseus-pharmaceuticals-confirms-receipt-of-unsolicited-expression-of-interest-from-foresite-capital-llc-and-orbimed-advisors-llc-and-unsolicited-proposal-from-concentra-biosciences-llc-301997491.html
https://www.fiercebiotech.com/biotech/months-after-ending-cancer-program-theseus-lays-72-staff-it-considers-options
https://ir.theseusrx.com/2023-11-13-Theseus-Pharmaceuticals-Announces-Process-to-Explore-Strategic-Alternatives
https://www.prnewswire.com/news-releases/theseus-pharmaceuticals-to-participate-in-the-stifel-2023-healthcare-conference-301980328.html
https://www.prnewswire.com/news-releases/theseus-pharmaceuticals-to-discontinue-enrollment-in-phase-12-study-and-terminate-development-of-the-630-in-patients-with-gist-301877076.html
https://www.prnewswire.com/news-releases/theseus-pharmaceuticals-reports-initial-dose-escalation-data-from-ongoing-phase-12-trial-of-the-630-in-patients-with-advanced-gist-301835043.html
https://www.prnewswire.com/news-releases/theseus-pharmaceuticals-announces-business-highlights-and-reports-first-quarter-2023-financial-results-301821751.html